MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

pSivida Corp. Company Profile (NASDAQ:PSDV)

Consensus Ratings for pSivida Corp. (NASDAQ:PSDV) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.75 (138.52% upside)

Analysts' Ratings History for pSivida Corp. (NASDAQ:PSDV)
Show:
DateFirmActionRatingPrice TargetActions
6/23/2016FBR & Co.Reiterated RatingBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/29/2015Ladenburg ThalmannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2015Northland SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2015MLV & Co.Reiterated RatingBuy$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for pSivida Corp. (NASDAQ:PSDV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
9/7/2016        
5/5/2016Q3($0.20)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q116($0.15)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/9/2015Q415($0.14)($0.17)$409.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2015Q315($0.13)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2015($0.13)($0.14)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2014Q3 14($0.12)$0.67$25.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/9/2014Q414($0.15)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2014Q314($0.15)($0.03)$0.55 million$2.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/7/2014Q214($0.13)($0.13)$430.00 million$0.59 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q1($0.14)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/25/2013Q413($0.12)($0.17)$0.65 million$0.49 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2013Q2 2013($0.11)$0.63 million$0.59 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q113($0.10)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for pSivida Corp. (NASDAQ:PSDV)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20161($0.10)($0.10)($0.10)
(Data provided by Zacks Investment Research)
Dividend History for pSivida Corp. (NASDAQ:PSDV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for pSivida Corp. (NASDAQ:PSDV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
1/4/2016Leonard S. RossVPSell5,000$4.70$23,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2015Leonard S. RossVPSell33,950$5.39$182,990.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2015Paul AshtonCEOSell120,000$5.39$646,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Paul AshtonCEOSell10,000$4.27$42,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Paul AshtonCEOSell10,000$4.78$47,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Paul AshtonCEOSell10,000$4.37$43,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Paul AshtonCEOSell10,000$4.32$43,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2014Paul AshtonCEOSell7,000$4.00$28,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2014Lori FreedmanVPSell7,900$4.00$31,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2014Paul AshtonCEOSell7,700$4.00$30,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2014Lori FreedmanVPSell11,700$4.02$47,034.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2014Paul AshtonCEOSell11,800$4.02$47,436.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2012Paul HopperDirectorBuy10,000$1.68$16,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for pSivida Corp. (NASDAQ:PSDV)
DateHeadline
06/30/16 06:13 PMUpdate on Stock Volatility for: pSivida Corp. (NASDAQ:PSDV) - Engelwood Daily
06/29/16 05:50 PMpSivida Corp. (NASDAQ:PSDV) Company Rating and Target Watch - Telanagana Press
06/27/16 10:03 AMShare Update and Earnings Review for pSivida Corp. (NASDAQ:PSDV) - Press Telegraph
06/27/16 10:03 AMStock Volatility in Review: pSivida Corp. (NASDAQ:PSDV) - Engelwood Daily
06/03/16 08:50 AMShare Rating Focus on pSivida Corp. (NASDAQ:PSDV) - HNN - Share Rating Focus on pSivida Corp. (NASDAQ:PSDV)HNNPresently, Wall Street analysts have given a consensus stock rating of 1 on shares of pSivida Corp. (NASDAQ:PSDV). Covering analysts will typically provide Buy, Sell, or Hold recommendations based on extensive research. This consensus number is ...and more »
06/02/16 08:58 AMTarget Price and Stock Performance Rundown for pSivida Corp. (NASDAQ:PSDV) - HNN - Target Price and Stock Performance Rundown for pSivida Corp. (NASDAQ:PSDV)HNNKeeping an eye on share activity using multiple views may be helpful when tracking stock performance. Equity investors have the ability to track short or long term share performance. During the latest trading session, pSivida Corp. (NASDAQ:PSDV) shares ...and more »
06/02/16 08:58 AMPSivida Corp. (PSDV) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - PSivida Corp. (PSDV) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of pSivida Corp. (PSDV). The latest reports which are currently in issue on Thursday 2nd of June state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
06/01/16 06:30 PMpSivida Corp. (NASDAQ:PSDV) Stock Update & Estimates - Stock Tick Tock - pSivida Corp. (NASDAQ:PSDV) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting pSivida Corp. (NASDAQ:PSDV) to post earnings of $-0.17 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be issued around ...and more »
05/29/16 12:42 PMPerformance at a Glance on pSivida Corp. (NASDAQ:PSDV) - HNN - Performance at a Glance on pSivida Corp. (NASDAQ:PSDV)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how pSivida Corp. (NASDAQ:PSDV)'s stock has performed at various points in its past. Currently, the stock ...and more »
05/28/16 12:05 PMpSivida (PSDV) Fluctuates Upward; Deutsche Bank Doubles PT On Vivint Solar (VSLR) - Galaxy Stocks (press release) (registration) - pSivida (PSDV) Fluctuates Upward; Deutsche Bank Doubles PT On Vivint Solar (VSLR)Galaxy Stocks (press release) (registration)The price of pSivida Corp. (Nasdaq:PSDV) stock climbed $0.75 (or +24.19%) to $3.85, and a total of 355,191 of its shares were traded on Friday, a large increase in activity versus its average volume (3m) of 82,270. There appears to be no confirmed news ...
05/27/16 01:08 PMStock Rating Review for pSivida Corp. (NASDAQ:PSDV) - Wall Street Hints and News - Stock Rating Review for pSivida Corp. (NASDAQ:PSDV)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 1 on shares of pSivida Corp. (NASDAQ:PSDV). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus rating is ...and more »
05/26/16 12:10 PMTarget Check and Stock Performance Recap pSivida Corp. (NASDAQ:PSDV) - Wall Street Hints and News - Target Check and Stock Performance Recap pSivida Corp. (NASDAQ:PSDV)Wall Street Hints and NewsIn recent session activity, pSivida Corp. (NASDAQ:PSDV) shares have traded -1.32%. Monitoring the stock price relative to moving averages may provide enhanced perspective on share performance. After a recent check, the stock has been recorded $0.04 ...and more »
05/20/16 11:51 AMBroker Roundup For PSivida Corp. (PSDV) - Share Trading News - Broker Roundup For PSivida Corp. (PSDV)Share Trading News11/26/2013 – pSivida Corp. was upgraded to “neutral” by analysts at Zacks. They now have a USD 2.7 price target on the stock. The share price of pSivida Corp. (PSDV) was up +0.71% during the last trading session, with a day high of 2.83. 2800 shares ...
05/18/16 12:15 PMAfter Last Week What Do Analysts Think Of PSivida Corp. (PSDV) - Share Trading News - After Last Week What Do Analysts Think Of PSivida Corp. (PSDV)Share Trading News11/26/2013 – pSivida Corp. was upgraded to “neutral” by analysts at Zacks. They now have a USD 2.7 price target on the stock. The share price of pSivida Corp. (PSDV) was up +0.73% during the last trading session, with a day high of 2.79. 33402 shares ...
05/18/16 12:15 PMRevenue Update on pSivida Corp.(NASDAQ:PSDV) - Trade Calls - Revenue Update on pSivida Corp.(NASDAQ:PSDV)Trade CallspSivida Corp.(NASDAQ:PSDV) announced the earnings results for Fiscal Year 2016 and Q3. The results came in during After-hours on May 5, 2016. Company reported revenue of $324.00K. Analysts estimated a revenue of $500.00K. Earnings per share ...and more »
05/14/16 05:50 AMConsensus Rating Review for pSivida Corp. (NASDAQ:PSDV) - Wall Street Hints and News - Consensus Rating Review for pSivida Corp. (NASDAQ:PSDV)Wall Street Hints and NewsEquity research analysts currently have a consensus rating of 1 on shares of pSivida Corp. (NASDAQ:PSDV). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy, Sell, or Hold ...and more »
05/12/16 12:09 PMpSivida Corp. :PSDV-US: Earnings Analysis: Q3, 2016 By the Numbers -
05/12/16 06:11 AMPsivida Corporation (NASDAQ:PSDV) Short Interest Decreased By 2.61% - B.O.D.Y Confidential - Psivida Corporation (NASDAQ:PSDV) Short Interest Decreased By 2.61%B.O.D.Y ConfidentialThe stock of Psivida Corporation (NASDAQ:PSDV) registered a decrease of 2.61% in short interest. PSDV's total short interest was 987,200 shares in May as published by FINRA. Its down 2.61% from 1.01 million shares, reported previously. With 84,800 ...
05/08/16 05:34 AMAverage Analyst Rating for pSivida Corp. (NASDAQ:PSDV) - B.O.D.Y Confidential - Average Analyst Rating for pSivida Corp. (NASDAQ:PSDV)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1 on pSivida Corp. (NASDAQ:PSDV) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/06/16 11:40 AMPSIVIDA CORP. Files SEC form 10-Q, Quarterly Report -
05/05/16 05:20 PMPSivida reports 3Q loss -
05/05/16 03:11 PMpSivida Corp. Provides Company Update and Reports Third Quarter FY 2016 Results - [at noodls] - May 5, 2016 WATERTOWN, Mass., May 05, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, ...
05/05/16 06:07 AMQ3 2016 pSivida Corp Earnings Release - After Market Close -
05/04/16 07:10 AMpSivida CEO to Present at 2016 International Symposium of Ocular Pharmacology and Therapeutics - [at noodls] - May 4, 2016 WATERTOWN, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, ...
05/04/16 04:17 AMpSivida's (PSDV) Medidur Granted Orphan Drug Designation in Europe as Uveitis Treatment - StreetInsider.com - pSivida's (PSDV) Medidur Granted Orphan Drug Designation in Europe as Uveitis TreatmentStreetInsider.compSivida Corp. (Nasdaq : PSDV) announced that the European Commission granted orphan medicinal product designation to Medidur for the treatment of chronic non-infectious uveitis of the posterior of the eye (posterior uveitis). “Receiving designation as ...
05/02/16 06:40 AMpSivida's Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe - [at noodls] - May 2, 2016 WATERTOWN, Mass., May 02, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, ...
05/02/16 06:30 AMpSivida’s Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe - [GlobeNewswire] - WATERTOWN, Mass., May 02, 2016-- pSivida Corp., a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that the European Commission granted orphan ...
05/02/16 05:40 AMPSivida Corp. (PSDV) Broker Price Targets For The Coming Week - Share Trading News - PSivida Corp. (PSDV) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of pSivida Corp. (PSDV). The latest reports which are currently in issue on Monday 2nd of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts ...
05/01/16 05:41 AMpSivida Corp. (NASDAQ:PSDV) Basic Consolidated EPS At $0.216 - Investor Newswire - pSivida Corp. (NASDAQ:PSDV) Basic Consolidated EPS At $0.216Investor NewswireThe basic per-share earnings from continuing operations as confirmed by pSivida Corp. (NASDAQ:PSDV) for the period closed 2015-06-30 was $0.216. For the quarter ended 2015-06-30, this number was $0.216. For any specified company's stock there are ...
04/27/16 08:06 AMpSivida Corp. Announces Third Quarter Fiscal Year 2016 Financial Results Release Date and Conference Call Information - [at noodls] - April 27, 2016 WATERTOWN, Mass., April 27, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, ...
04/27/16 06:36 AMpSivida Corp. (NASDAQ:PSDV) Wall Street Rating in Focus - News Tribune - pSivida Corp. (NASDAQ:PSDV) Wall Street Rating in FocusNews TribuneZacks.com, founded by Len Zacks, a Mathematics Ph.D. from M.I.T. who discovered that earnings estimate revisions are the most powerful force impacting stock prices, track 3 equity research firms that cover shares of pSivida Corp. (NASDAQ:PSDV). Sell ...and more »
04/27/16 06:36 AMpSivida Corp. (NASDAQ:PSDV) Share Rating Recap - The Post - pSivida Corp. (NASDAQ:PSDV) Share Rating RecapThe PostShares of pSivida Corp. (NASDAQ:PSDV) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...Buy Calls For pSivida Corp. (NASDAQ:PSDV) Stands At 0Equities Focusall 183 news articles »
04/27/16 06:36 AMPSivida Corp. (PSDV) Analyst Review - Risers & Fallers - PSivida Corp. (PSDV) Analyst ReviewRisers & FallersA number of investment brokers have recently updated their price targets on shares of pSivida Corp. (PSDV). According to the latest broker reports outstanding on Wednesday 27th of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
04/26/16 06:12 AMMid-Morning Market Update: Markets Open Lower; Xerox Profit Misses Views - Benzinga - Mid-Morning Market Update: Markets Open Lower; Xerox Profit Misses ViewsBenzingaLeading the sector was strength from pSivida Corp. (NASDAQ: PSDV) and Valeant Pharmaceuticals Intl Inc (NYSE: VRX). In trading on Monday, basic materials shares fell by 1.13 percent. Meanwhile, top losers in the sector included Resolute Forest Products ...and more »
04/23/16 05:57 AMPsivida Corporation (NASDAQ:PSDV) Shorts Decreased by 2.27% After Short Covering - CCH Daily News - Psivida Corporation (NASDAQ:PSDV) Shorts Decreased by 2.27% After Short CoveringCCH Daily NewsThe stock of Psivida Corporation (NASDAQ:PSDV) registered a decrease of 2.27% in short interest. PSDV's total short interest was 1.01M shares in April as published by FINRA. Its down 2.27% from 1.04M shares, reported previously. With 86,000 shares ...and more »
04/22/16 06:25 AM2 Small Biotech Stocks Poised For Substantial Upside - Seeking Alpha - Seeking Alpha2 Small Biotech Stocks Poised For Substantial UpsideSeeking AlphaThe biotech and biopharma sectors are starting to rally as the long and deep bear market that has cast a pall on these sectors seems to be over. Today we highlight two promising but speculative small caps within these areas that could ride this change ...
04/13/16 11:47 AMpSivida Corp. (NASDAQ:PSDV): Quick Look at Earnings - News Tribune - pSivida Corp. (NASDAQ:PSDV): Quick Look at EarningsNews TribuneWhen pSivida Corp. (NASDAQ:PSDV) issues their next quarterly report on or near 2016-05-13, Wall Street analysts are predicting they will report earnings per share of $-0.19. This consensus EPS number is provided by Zacks Research, which might differ ...and more »
04/13/16 11:47 AMpSivida Corp. (NASDAQ:PSDV) Analyst Recommendation Outlook - Clinton Financial - pSivida Corp. (NASDAQ:PSDV) Analyst Recommendation OutlookClinton FinancialCovering analysts usually give Buy, Sell and Hold recommendations along with guidance and company earnings estimates. There are 3 analysts providing ratings for pSivida Corp. (NASDAQ:PSDV). 3 have given the stock a “Strong Buy”, 0 rate it a “Buy”, ...and more »
04/13/16 11:47 AMPsivida Corp (NASDAQ:PSDV) Institutional Investors Sentiment Up in 2015 Q3 - RiversideGazette.com - Equities.comPsivida Corp (NASDAQ:PSDV) Institutional Investors Sentiment Up in 2015 Q3RiversideGazette.comPsivida Corp (NASDAQ:PSDV) institutional sentiment increased to 1.5 in Q3 2015. Its up 0.12, from 1.38 in 2015Q2. The ratio is more positive, as 18 funds increased and opened new positions, while 13 sold and reduced equity positions in Psivida Corp.PSivida Corp. (PSDV) Updated Analyst CoverageRisers & FallersResults for pSivida (PSDV) set Table for upcoming QuarterEquities.comall 3 news articles »
04/09/16 08:59 AMAnalyst Ratings Check pSivida Corp. (NASDAQ:PSDV) - Business Standard Tribune - Analyst Ratings Check pSivida Corp. (NASDAQ:PSDV)Business Standard TribuneCovering sell-side analysts have an average rating of 1 on shares of pSivida Corp. (NASDAQ:PSDV). This Zacks Research number is compiled from analysts that they have taken into consideration. This consensus rating lands on a 1 to 5 scale. A 1 or 2 ...and more »
04/09/16 08:59 AMPsivida Corporation (NASDAQ:PSDV) Shorts Decreased by 4.37% After Short Covering - Clinton Financial - Psivida Corporation (NASDAQ:PSDV) Shorts Decreased by 4.37% After Short CoveringClinton FinancialThe stock of Psivida Corporation (NASDAQ:PSDV) registered a decrease of 4.37% in short interest. PSDV's total short interest was 1.04 million shares in April as published by FINRA. Its down 4.37% from 1.08M shares, reported previously. With 88,900 ...
02/13/16 12:04 PMPSIVIDA CORP. Financials -
02/11/16 09:51 AMpSivida Corp. Earnings Analysis: Q2, 2016 By the Numbers -
02/09/16 05:05 AMPSIVIDA CORP. Files SEC form 8-K, Change in Directors or Principal Officers -
02/08/16 11:01 PMEdited Transcript of PSDV earnings conference call or presentation 8-Feb-16 9:30pm GMT -
02/08/16 03:30 PMpSivida Corp Earnings Call scheduled for 4:30 pm ET today -
02/08/16 03:20 PMPSivida reports 2Q loss - [AP] - The Watertown, Massachusetts-based company said it had a loss of 18 cents per share. The drug delivery technology company posted revenue of $526,000 in the period. In the final minutes of trading on Monday, ...
02/08/16 03:02 PMPSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
02/08/16 03:01 PMpSivida Corp. Provides Company Update and Reports Second Quarter FY 2016 Results - [GlobeNewswire] - WATERTOWN, Mass., Feb. 08, 2016-- pSivida Corp.,, a leader in the development of sustained release drug delivery products for treating eye diseases, today provided a Company update and announced financial ...
02/08/16 06:07 AMQ2 2016 pSivida Corp Earnings Release - After Market Close -
About pSivida Corp.

pSivida Corp. logopSivida Corp. is a biotechnology company, which is engaged in the development of sustained-release drug-delivery products for treating eye diseases. The Company offers products for treatment of back-of-the-eye diseases. The Company's lead development product, Medidur is used for posterior of the eye (posterior uveitis). Medidur is in Phase III clinical trials. The Company's pre-clinical development program is focused on developing products using its platform technologies, Durasert and Tethadur, to deliver drugs and biologics to treat ophthalmic diseases, such as wet and dry age-related macular degeneration (AMD), glaucoma and osteoarthritis, among others. Its Durasert technology platform delivers therapeutics for predetermined periods of time ranging from days to years. Its Tethadur technology system utilizes BioSilicon, nanostructured elemental silicon, designed to provide sustained delivery of biologic molecules, such as peptides, proteins and antibodies.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PSDV
  • CUSIP:
Key Metrics:
  • Previous Close: $2.83
  • 50 Day Moving Average: $3.13
  • 200 Day Moving Average: $3.21
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $96.71M
  • Current Quarter EPS Consensus Estimate: $-0.62 EPS
Additional Links:
pSivida Corp. (NASDAQ:PSDV) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha